Anil Achyuta is an Investment Director at TDK Ventures. He is passionate about the energy and healthcare sectors, as he believes these are the most impactful areas in building a sustainable future, a mission that is directly in line with TDK Ventures’ goals. Of his eleven investments, he has secured two exits: GenCell IPO’d on the Tel Aviv Stock Exchange (GNCL:IT), and Origin, which was acquired by the #1 3-D printing company in the world, Stratasys, for $100M.
Prior to TDK Ventures, Anil held leadership roles at Fortune 500 companies including L’Oréal, Johnson & Johnson, GlaxoSmithKline, and Draper.
Anil was voted one of the Rising Stars in 2021 by Venture Capital Journal and was ranked the #2 Rising Star in 2021 out of 20,000 corporate venture managers globally. He was also voted as one of the Emerging Leaders of 2022 by Global Corporate Venturing. He is a published author in polymer science, neural engineering, microfluidics, and tissue engineering with 11 peer-reviewed publications, two book chapters, and six US patents.
He has a Ph.D. in Chemical Engineering from Northeastern University and received his M.B.A. from the University of Florida Warrington College of Business.
Anil was born and raised in Bangalore, India in a family of teachers, and speaks fluent Kannada, Hindi. He loves sports and music. He was a former cricket player, and currently plays tennis, table tennis, racquetball, and cricket occasionally. He loves playing guitar and listening to classic rock.